NCT04881201View on ClinicalTrials.gov

Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A)

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

June 10, 2024

Study Completion Date

June 10, 2024

Conditions
Charcot-Marie-Tooth Disease Type 2A
Interventions
PROCEDURE

blood sample

blood sample

Trial Locations (1)

49933

CHU, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT04881201 - Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A) | Biotech Hunter | Biotech Hunter